VictoryShares International High Div Volatility Wtd ETF CID 深 滬
等待開盤 10-11 09:30:00 美东时间
33.015
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 33.015
- 總市值 1980.90万
- 52周最高 34.2569
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 27.0851
- 委 比 0.00%
- 總股本 60.00万
- 歷史最高 34.2569
- 量 比 0
- 振 幅 0.00%
- 歷史最低 12.3603
- 每 手 1
- 風險率 0.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多What 7 Analyst Ratings Have To Say About Ares Capital
Across the recent three months, 7 analysts have shared their insights on Ares C...
今天 04:01
Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.
STOCKHOLM, Oct. 6, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab-irmb subcutaneous injection (U.S. brand name: Leqembi Iq...
10-07 06:02
LUCID CAPITAL MARKETS Initiates Coverage On Cassava Sciences with Buy Rating, Announces Price Target of $8
LUCID CAPITAL MARKETS analyst Elemer Piros initiates coverage on Cassava Sciences (NASDAQ:SAVA) with a Buy rating and announces Price Target of $8.
10-06 20:50
Leqembi® approved for IV maintenance treatment in China
STOCKHOLM, Sept. 29, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab (Leqembi) has been approved for once every four weeks ...
09-29 14:34
Jaguar Health Receives Notice Of $250K Grant From FDA's Center For Veterinary Medicine To Support Confirmatory Study For Canalevia-CA1 For Chemotherapy-Induced Diarrhea In Dogs
Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar"), under its Jaguar Animal Health tradename for the veterinary market, today announced that it has received notice from the U.S. Food and Drug Administration's Center for Veterinary Medicine (CVM) of a $250,000 grant.
09-25 21:05
申万宏源：首予再鼎医药“买入”评级 目标价35.2港元
申万宏源发布研报称，随着商业化产品的销售放量，以及本地化生产布局，再鼎医药（09688）预计将于2025年四季度实现non-GAAP经营利润。此外，该行预计2...
09-24 10:21
FUJIFILM Biotechnologies Expands Strategic Partnership With argenx To Include U.S. Manufacturing Operations
Expansion of partnership broadens argenx' manufacturing capabilities in the U.S., supporting its strategy of local-for-local supply of medicinesHOLLY SPRINGS, N.C.--(BUSINESS WIRE)--FUJIFILM Biotechnologies, a
09-18 21:15
LUCID CAPITAL MARKETS Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9
LUCID CAPITAL MARKETS analyst Christopher Liu initiates coverage on Adagene (NASDAQ:ADAG) with a Buy rating and announces Price Target of $9.
09-18 20:21
Lilly's oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial
For the primary endpoint, orforglipron lowered A1C by 2.2% vs. 1.4% with oral semaglutide at the highest doses Participants taking the highest dose of orforglipron lost an average of 19.7 lb...
09-17 21:00
Colgate Agrees To Show Safe Toothpaste Amounts For Kids After Legal Pressure
Attorney General Paxton secured a deal with Colgate to ensure kids' toothpaste ads show safe, age-appropriate amounts starting in November 2025..
09-17 02:06
